Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 1
2011 1
2012 1
2016 2
2018 1
2020 3
2021 3
2022 6
2023 5
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

22 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean alam alghamdi (57 results)?
Informing a cost-effectiveness threshold for Saudi Arabia.
Al-Jedai AH, Lomas J, Almudaiheem HY, Al-Ruthia YSH, Alghamdi S, Awad N, Alghamdi A, Alowairdhi MA, Alabdulkarim H, Almadi M, Bunyan RF, Ochalek J. Al-Jedai AH, et al. Among authors: alghamdi a. J Med Econ. 2023 Jan-Dec;26(1):128-138. doi: 10.1080/13696998.2022.2157141. J Med Econ. 2023. PMID: 36576804 Free article.
Ceftolozane-tazobactam vs. colistin for the treatment of infections due to multidrug-resistant Pseudomonas aeruginosa: a multicentre cohort study.
Almangour TA, Aljabri A, Al Musawa M, Almohaizeie A, Almuhisen S, Damfu N, Alfozan A, Alraddadi BM, Alattas M, Qutub M, Alhameed AF, Khuwaja M, Alghamdi A, Binkhamis KM, Alfahad W, AlShahrani FS. Almangour TA, et al. Among authors: alghamdi a. J Glob Antimicrob Resist. 2022 Mar;28:288-294. doi: 10.1016/j.jgar.2022.01.023. Epub 2022 Feb 1. J Glob Antimicrob Resist. 2022. PMID: 35121161 Free article.
Evaluation of ceftazidime/avibactam for treatment of carbapenemase-producing carbapenem-resistant Enterobacterales with OXA-48 and/or NDM genes with or without combination therapy.
Alqahtani H, Alghamdi A, Alobaidallah N, Alfayez A, Almousa R, Albagli R, Shamas N, Farahat F, Mahmoud E, Bosaeed M, Abanamy R. Alqahtani H, et al. Among authors: alghamdi a. JAC Antimicrob Resist. 2022 Oct 11;4(5):dlac104. doi: 10.1093/jacamr/dlac104. eCollection 2022 Oct. JAC Antimicrob Resist. 2022. PMID: 36237571 Free PMC article.
22 results